scholarly journals Severity of Alveolar Bone Loss in Control and Uncontrolled Type II Diabetics

2021 ◽  
Vol 15 (6) ◽  
pp. 1459-1462
Author(s):  
A. Farooq ◽  
M. Riasat ◽  
H. K. N. Baloch ◽  
S. G. S. Shah ◽  
S. Shehzad ◽  
...  
Keyword(s):  
Bone Loss ◽  
Glucose Level ◽  
Alveolar Bone ◽  
Alveolar Bone Loss ◽  
Radiology Department ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Severe Bone Loss ◽  
Type 2 Diabetic

Objective: To assess the association between the controlled and uncontrolled type-2 diabetic patients to the severity of Alveolar bone loss Study Designed: Cross-sectional analytical study. Place and Duration of Study: Department of Radiology, Sardar Begum Dental College and Khyber College of Dentistry Peshawar KPK from 1st October 2020 to 31st March 2021. Methodology: One hundred and seventy patients were included. Daniel formula (1999) was used for the patient to check the alveolar bone loss and questionnaire was filled by the researcher and examination was done on the dental unit using examination instruments. Results: The mean age was 39.41±6.92. The oral hygiene status in patients visiting the radiology department using toothpaste twice a day was 50.58% while bone loss among patient using toothpaste and brushing their teeth twice a day was 21.51%. The patient with a controlled glucose level was 41.28% while a patient with an uncontrolled glucose level was 58.72%. The bone loss in a patient with controlled HbA1c the bone loss in normal to moderate 38.38%while severe bone loss was 2.90% which is less as compared to the controlled group. The bone loss was reported higher in males (51.16%)as in females were 48.84%, but there was a severe bone loss in females 31,40% as compared to males 17.44%. Conclusion: There is a strong association between alveolar bone loss with the increased level of HbA1c. When the levels of HbA1c level increased the bone loss in both male and female was reported high. Type 2 diabetic patients having increased HbA1c levels cause severe bone loss. Keywords: Diabetes mellitus, Out-patient department, Hemoglobin A1c

Decrease in serum leptin by troglitazone is associated with preventing bone loss in type 2 diabetic patients

2003 ◽  
Vol 21 (3) ◽  
pp. 166-171 ◽  
Author(s):  
Sumiyo Watanabe ◽  
Yasuhiro Takeuchi ◽  
Seiji Fukumoto ◽  
Hiroko Fujita ◽  
Tadasumi Nakano ◽  
...  
Keyword(s):  
Bone Loss ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Serum Leptin ◽  
Type 2 Diabetic

Lower occurrence of low blood glucose level in elderly type 2 diabetic patients treated with gliclazide versus glibenclamide

2007 ◽  
Vol 7 (1) ◽  
pp. 91-93 ◽  
Author(s):  
Kenzo Oba ◽  
Yuki Inuzuka ◽  
Naoko Yamashita-Onodera ◽  
Kentaro Watanabe ◽  
Noriaki Matsumura ◽  
...  
Keyword(s):  
Blood Glucose ◽  
Blood Glucose Level ◽  
Glucose Level ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Type 2 Diabetic

Effects of ginger (Zingiber officinale) on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patients

2013 ◽  
Vol 64 (6) ◽  
pp. 682-686 ◽  
Author(s):  
Sepide Mahluji ◽  
Vahide Ebrahimzade Attari ◽  
Majid Mobasseri ◽  
Laleh Payahoo ◽  
Alireza Ostadrahimi ◽  
...  
Keyword(s):  
Insulin Sensitivity ◽  
Glucose Level ◽  
Plasma Glucose ◽  
Plasma Glucose Level ◽  
Zingiber Officinale ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Type 2 Diabetic

scholarly journals THE CHARACTERISTIC OF ERECTILE DYSFUNCTION AMONG TYPE 2 DIABETES MELLITUS MALE IN EASTERN INDONESIA

2021 ◽  
Vol 28 (1) ◽  
pp. 14-18
Author(s):  
Andy Zulfiqqar ◽  
Franky Renato Anthonius ◽  
Prasetyo Amanda Cyko ◽  
Pandu Ishaq Nandana ◽  
Prahara Yuri ◽  
...  
Keyword(s):  
Erectile Dysfunction ◽  
Glucose Level ◽  
District Hospital ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Cross Sectional ◽  
Uncontrolled Diabetes ◽  
Type 2 Diabetic

Objective: To determine Type-2 diabetic patients and its characteristics to determined risk of Erectile dysfunction (ED) and the role of EHS score as more practical tools to screening ED among T2DM patients. Material & Methods: The cross-sectional observational study was carried out at the Internal medicine Unit of Manambai Abdulkadir and Dompu district Hospital, out of 45 patients were included on this study. The data were collected from June 01 – August 01 2017. A structural questioner was used to collect the data and was analyzed using SPSS 2.0. person analysis correlation and logistic regression were used to find the Odds Ratio (OR). Results: We found that 38 out of 45 (84.4%) patients (mean age 57.2 ± 7.1) have Erectile dysfunction, 26 patients uncontrolled diabetes, 5 (11.1%) treated as CHF, 4 (8.9%) CKD, and 7 (15.6%) neuropathy diabetic. There is high correlation between random glucose level and IIEF-5 score (r=0.5, p=0.01). The overall odd ratio of ED in this studies was 4.3 (95% CI: 0.73 to 25.1) for uncontrolled diabetes, 2.5 (95% CI: 0.1 to 51.1) for Treated CHF, 2 (95% CI: 0.01 to 41.6) for CKD, and it was 1.2 (95% CI: 0.1 to 11.5) for neuropathy diabetics. Conclusion: From this study, we found that most diabetic patients have ED, and there is high correlation between random glucose level and simplified IIEF-5 score, EHS performed similar result on diagnoses ED compared to IIEF-5.

scholarly journals Study the action of pycnogenol on glucose and lipid profile in type -2- diabetic patients

2019 ◽  
Vol 17 (72) ◽  
pp. 35-46
Author(s):  
Rasha Zuhair ◽  
Dr.Amar Maola Hmod
Keyword(s):  
Glucose Level ◽  
Biochemical Parameters ◽  
Low Density Lipoproteins ◽  
Control Group ◽  
Diabetic Patients ◽  
Low Density ◽  
Very Low Density Lipoproteins ◽  
Type 2 Diabetic Patients ◽  
Type 2 Diabetic

Pycnogenol  pinus pinaster Ait ( a water extract of polyphenolic compounds ) was extracted from Iraqi pine bark and analyzed using high performance liquid chromotography (HPLC) coupled to ultra violet UV detection that was recorded at (254 nm).            Pycnogenol action on some biochemical parameters (glucose , total cholesterol (TC) , triacylglycerol (TG) , high density lipoproteins (HDL) ,low density lipoproteins (LDL) , very low density lipoproteins (VLDL) )level was determined in (30) type -2- diabetic patients who treated with capsules (500 mg) of pycnogenol three times daily to examine the reactive role of pycnogenol against oxidative stress.The above biochemical parameters were measured in plasma before treatment with pycnogenol and after (1 week) , (2 weeks) and (3 weeks) of treatment with this polyphenolic extract.            Our results have shown that  glucose level was increased relatively for diabetic patients compared with control group (p<0.001) but after treatment with pycnogenol , glucose level would be decreased relatively (p<0.001) after (1 week) , (p<0.001) after (2 weeks) and (p<0.05) after (3 weeks) of treatment with pycnogenol.Total cholesterol (TC) level increased relatively for diabetic patients compared with control group (p<0.001) , but after treatment with this reactive extract  (TC) level  decreased relatively (p<0.001) after (1 week) , (p<0.001) after (2 weeks) and (p<0.01) after (3 weeks) of treatment with pycnogenol.Triacylglycerol (TG) level was  increased relatively for diabetic patients compared with control group (p<0.001) , but after treatment with this antioxidant  extract  (TG) level decreased relatively (p<0.001) after (1 week) , (p<0.001) after (2 weeks) and (p<0.01) after (3 weeks) of treatment with pycnogenol.High density lipoproteins (HDL) level was decreased relatively for diabetic patients compared with control group (p<0.001) , but after treatment with pycnogenol (HDL) level increased relatively (p<0.01) after (1 week) , (p<0.01) after (2 weeks) and (p<0.05) after (3 weeks) of treatment with pycnogenol.Low density lipoproteins (LDL) level increased relatively for diabetic patients compared with control group (p<0.001) , but after treatment with  pycnogenol , (LDL) level decreased relatively (p<0.001) after (1 week) , (p<0.001) after (2 weeks) and (p<0.01) after (3 weeks) of treatment with pycnogenol. Very low density lipoproteins (VLDL) level increased relatively for diabetic patients compared with control group (p<0.001) , but after treatment with  pycnogenol , (VLDL) level decreased relatively (p<0.001) after (1 week) , (p<0.001) after (2 weeks) and (p<0.01) after (3 weeks) of treatment with pycnogenol.

Sign in / Sign up

Export Citation Format

Share Document